Evidence map›Paper›PMID 30848227›Full record

ReviewCurrent molecular pharmacology2019

The Endocrine Disruptor Bisphenol A (BPA) Exerts a Wide Range of Effects in Carcinogenesis and Response to Therapy.

Shirin A Hafezi, Wael M Abdel-Rahman

Registry-linked trialAbstract readReview
In one paragraph

Review in Current molecular pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06107933 (Developmental Impacts of MicroPLastics Exposure in Early Life), which is not on this map. Cited by 65 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 3 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06107933 recruitingnot on this mapstarted 2023, after this paper: background citation

Developmental Impacts of MicroPLastics Exposure in Early Life

TypeobservationalSponsorJohns Hopkins Bloomberg School of Public HealthRan2023 to 2027Enrolled40ConditionsInfant Development, Breast Feeding, Environmental ExposureArmsObservational only
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 3 syntheses or guidelines pooled it, 149 citations in OpenAlex.

  1. Pooled it
  2. A Review of Biomonitoring for Atrazine and Atrazine Metabolites Using Blood, Urine, and Sweat-Based Assays.International journal of environmental research and public health · 2026
    Pooled it
  3. Pooled it
  4. Article
  5. AI/ML-based computational models for toxicity prediction.Environmental science and pollution research international · 2026
    Review
  6. Article
  7. Endocrine Disruptors and Gynecological Malignancies.Diagnostics (Basel, Switzerland) · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shirin A HafeziSharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.
Wael M Abdel-RahmanSharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.
University of Sharjah · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBisphenol A (BPA) is a synthetic plasticizer that is commonly used in the production of polycarbonate plastics and epoxy resins. Human exposure occurs when BPA migrates from food and beverage containers into the contents when heated or even under normal conditions of use. BPA exerts endocrine disruptor action due to its weak binding affinity for the estrogen receptors ERα and ERβ. BPA exerts other effects by activating the membrane receptor GPER (GPR30) and/or other receptors such as the estrogen-related receptors (ERRs).

objectiveThis review summarizes emerging data on BPA and cancer. These include data linking exposure to BPA with an increased risk of hormone-related cancers such as those of the ovary, breast, prostate, and even colon cancer. BPA can also induce resistance to various chemotherapeutics such as doxorubicin, cisplatin, and vinblastine in vitro. The development of chemoresistance to available therapeutics is an emerging significant aspect of BPA toxicity because it worsens the prognosis of many tumors.

conclusionRecent findings support a causal role of BPA at low levels in the development of cancers and in dictating their response to cytotoxic therapy. Accurate knowledge and consideration of these issues would be highly beneficial to cancer prevention and management.

Indexed as

AnimalsAntineoplastic AgentsBenzhydryl CompoundsBisphenol A CompoundsCarcinogenesisDrug Resistance, NeoplasmEndocrine DisruptorsHumansNeoplasmsPhenolsPrognosisAntineoplastic AgentsBenzhydryl Compoundsbisphenol ABisphenol A CompoundsEndocrine DisruptorsPhenolsBisphenol A (BPA)breast cancerchemotherapycolorectal cancerovarian cancerprostate cancer.

Identifiers

PMID30848227
PMCPMC6864600
OpenAlexW2921497398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.